Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNFα and nitrite/nitrate in human septic shock

Intensive Care Medicine

Volumn 24, Issue 7, 1998, Pages 673-679

  Avontuur, J A M ^a   Stam, T C ^a   Jongen Lavrencic, M ^b   Van Amsterdam, J G C ^c   Eggermont, A M M ^a   Bruining, H A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cytokines; L NAME; Nitric oxide; Nitric oxide synthase inhibition; Sepsis

Indexed keywords

ARGININE METHYL ESTER; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CORRELATION FUNCTION; FEMALE; HEART OUTPUT; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE;

APACHE; DRUG MONITORING; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE SYNTHASE; NITRITES; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031855150     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050643     Document Type: Article

References (36)

1. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 953-963
2. Parker MM, McCarthy KE, Ognibene FP et al (1990) Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97: 126-130
3. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev 43: 109-142
4. Avontuur JA, Bruining HA, Ince C (1997) Nitric oxide causes dysfunction of coronary autoregulation in endotoxemic rats. Cardiovasc Res 35: 368-376
5. Ochoa JB, Udekwu AO, Billiar TR et al (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214: 621-626
6. Gomez-jimenez J, Salgado A, Mourelle M et al (1995) L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23: 253-258
7. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87: 3629-3632
8. Meyer J, Traber LD, Nelson S et al (1992) Reversal of hyperdynamic responses to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73: 324-328
9. Landin L, Lorente JA, Renes E et al (1994) Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 106: 250-256
10. Lorente JA, Landin L, De Pablo R et al (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287-1295
11. Petros A, Lamb G. Leone A et al (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28: 34-39
12. Kiehl MG, Ostermann U, Meyer J, Kienast J (1997) Nitric oxide synlhase inhibition by L-NAME in leucocytopenic patients with severe septic shock. Intensive Care Med 23: 561-566
13. Fukatsu K, Saito H, Fukushima R et al (1995) Detrimental effects of a nitric oxide synthase inhibitor (N-ω -nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch Surg 130: 410-414
14. Tiao G, Rafferty J, Ogle C et al (1994) Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 116: 332-338
15. Friedland JS, Porter JC, Daryanani S et al (1996) Plasma proinflammatory cytokine concentrations, acute physiology and chronic health evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit Care Med 24: 1775-1781
16. Carlstedt F, Lind L, Lindahl B (1997) Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease. J Intern Med 242: 361-365
17. Thijs LG, Hack CE (1995) Time course of cytokine levels in sepsis. Intensive Care Med 21 (Suppl 2): S258-S263
18. Martin C, Boisson C, Haccoun M et al (1997) Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 25: 1813-1819
19. Cook HT, Cattell V (1996) Role of nitric oxide in immune-mediated disease. Clin Sci 91: 375-384
20. Meyer TA, Tiao GM, James JH et al (1995) Nitric oxide inhibits LPS-induced IL-6 production in enterocytes. J Surg Res 58: 570-575
21. Villarete LH, Remick DG (1997) Nitric oxide regulation of interleukin-8 gene expression. Shock 7: 29-35
22. Bone RC, Fischer CJ, Clemmer TP et al (1989) The sepsis syndrome: a valid clinical entity. Crit Care Med 17: 389-393
23. Stam TC, Jongen-Lavrencic M, Eggermont AM, Swaak AJ (1996) Effects of isolated limb perfusion with tumour necrosis factor-alpha on the function of monocytes and T lymphocytes in patients with cancer. Eur J Clin Invest 26: 1085-1091
24. Phizackerley PJ, Al-Dahhagh SA (1983) The estimation of nitrate and nitrite in saliva and urine. Anal Biochem 131: 242-245
25. Knaus WA, Le Gall JR, Wagner DP et al (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829
26. Lambert LE, Whitten JP, Baron BM et al (1991) Nitric oxide synthesis in the CNS, endothelium and macrophages differs in ils sensivity to inhibition by arginine analogues. Life Sci 48: 69-75
27. Leaf CD, Wishnok JS, Hurley JP et al (1990) Nitrate biosynthesis in rats, ferrets and humans. Precursor studies with L-arginine. Carcinogenesis 11: 855-858
28. Leone AM, Gustafsson LE, Francis PL et al (1994) Nitric oxide in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun 20: 883-887
29. Vallance P, Patton S, Bhagat K et al (1995) Direct measurement of nitric oxide in human beings. Lancet 345: 153-154
30. Beutler B, Cerami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316: 379-385
31. Havell EA (1989) Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 143: 2894-2901
32. Florquin S, Amraoui Z, Dubois C et al (1994) The protective role of endogenously synthesized nitric oxide in staphyloccocal enterotoxin B-induced shock in mice. J Exp Med 180: 1153-1158
33. Boczkowski J, Philip I, Tedgui A et al (1995) Effects of inhibition of nitric oxide synthesis on TNFα serum levels in E coli endotoxemic rats. Life Sci 57: 147-152
34. Renz H, Gong JH, Schmidt A et al (1988) Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J lmmunol 141: 2388-2393
35. Van Snick J (1990) Interleukin-6. An overview. Am Rev lmmunol 8: 253-278
36. Baggiolini M, Clark-Lews I (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307: 97-101